Cadrenal Therapeutics Inc —— 季度现金流量表 (NASDAQ:CVKD)

Financials

总资产 10.12 M7.95 M5.98 M4.09 M4.33 M 负债总额 2.68 M1.84 M1.68 M1.35 M1.59 M 权益总额 7.44 M6.11 M4.3 M2.73 M2.74 M 负债及股东权益总额 10.12 M7.95 M5.98 M4.09 M4.33 M 总债务 ————— 净债务 —————

新闻

Cadrenal schedules FDA meeting for HIT drug CAD-1005

Cadrenal Therapeutics股价因二期临床试验结果大涨

Cadrenal Therapeutics stock surges on Phase 2 trial results

Cadrenal的CAD-1005在HIT试验中显示血栓减少

Cadrenal’s CAD-1005 shows reduction in blood clots in HIT trial

Cadrenal强调12-LOX抑制剂对血液疾病的潜力

Cadrenal highlights potential of 12-LOX inhibitor for blood disorder

Cadrenal Therapeutics acquires first-in-class HIT treatment from Veralox

Cadrenal Therapeutics appoints PTC Therapeutics CMO to board

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics首席财务官Szot出售价值1496美元股票